A Universal Medication Schedule to promote patient understanding and use. Michael Wolf, PhD MPH Northwestern University Terry Davis, PhD Louisiana State University Health Sciences Center-Shreveport Ruth Parker, MD Emory University Will Shrank, MD Harvard Medical School . Acknowledgements.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
A Universal Medication Scheduleto promote patient understanding and use
Michael Wolf, PhD MPH
Terry Davis, PhD
Louisiana State University Health Sciences Center-Shreveport
Ruth Parker, MD
Will Shrank, MD
Harvard Medical School
Wolf, et al. Ann Intern Med 2006
Davis, et al., J Gen Intern Med, 2006
< 10% read them
Wolf, et al. Am J Health Sys Pharm, 2006
Value in Standardization!
Rx #: 1234567 9/8/2009
Do not drink alcoholic beverages while taking this medicine
You have 11 refills
An Enhanced Label and ‘UMS’
Take for Diabetes
Discard after 9/8/2010
Carry or wear medical identification stating you are taking this medicine
Provider: RUTH PARKER, MD
Emory Medical Center
2 pills in the morning
2 pills in the evening
You should avoid prolonged or excessive exposure to direct and/or artificial sunlight while taking this medicine
Pharmacy: NoVA ScriptsCentral
11445 Sunset Blvd.
NDC # 1234567
(ARR 2.00, 95% CI 1.44-2.42, p<0.001)
Patients with low literacy skills reported only (N=101)
Objective: to test the effectiveness of the evidence-based,
enhanced prescription drug container label design to improve
patients’ understanding of instructions for use.
2. Adherence (self-report, pill count, refill data)
3. HBA1C/Blood Pressure
- patients navigating multiple pharmacies for meds
- current pharmacy software (PDX) has significant limitations
i) hard coding of ‘sig’ font and size
ii) position of sig, indication, etc.
iii) emphasis options
iv) auxiliary warnings
- supplement in
- California Endowment grant
Contact Information:Michael S. Wolf, PhD MPHAssociate Professor, Medicine & Learning SciencesAssociate Division Chief – ResearchDivision of General Internal MedicineNorthwestern University Feinberg School of Medicine750 N. Lake Shore Drive, 10th FloorChicago, IL 60611(312) 503 – firstname.lastname@example.org